Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 15/20 | 0.62 |
| ▸ | IGF1R | P08069 | 13/20 | 0.62 |
| ▸ | ERBB4 | Q15303 | 12/20 | 0.62 |
| ▸ | AURKB | Q96GD4 | 5/20 | 0.62 |
| ▸ | BTK | Q06187 | 4/20 | 0.62 |
| ▸ | PLK4 | O00444 | 2/20 | 0.62 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.62 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.62 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.62 |
| ▸ | JAK2 | O60674 | 2/20 | 0.62 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.62 |
| ▸ | PAK4 | O96013 | 2/20 | 0.62 |
| ▸ | ABL1 | P00519 | 2/20 | 0.62 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.62 |
| ▸ | INSR | P06213 | 2/20 | 0.62 |
| ▸ | LCK | P06239 | 2/20 | 0.62 |
| ▸ | FYN | P06241 | 2/20 | 0.62 |
| ▸ | CDK1 | P06493 | 2/20 | 0.62 |
| ▸ | CSF1R | P07333 | 2/20 | 0.62 |
| ▸ | LYN | P07948 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL6435380 | 0.93 | EGFR (0.55) | EGFRIGF1RERBB4AURKBBTK | |
| Acetic Acid SCHEMBL4821510 | 0.93 | EGFR (0.71) | EGFRIGF1RERBB4AURKBBTK | |
| Acetic Acid SCHEMBL6430603 | 0.92 | EGFR (0.58) | EGFRIGF1RERBB4AURKBBTK | |
| SCHEMBL4819199 | 0.89 | EGFR (0.76) | EGFRIGF1RERBB4AURKBBTK | |
| SCHEMBL6430288 | 0.89 | EGFR (0.76) | EGFRIGF1RERBB4AURKBBTK | |
| SCHEMBL4818816 | 0.86 | EGFR (0.74) | EGFRIGF1RERBB4AURKBBTK | |
| SCHEMBL4823834 | 0.86 | EGFR (0.74) | EGFRIGF1RERBB4AURKBBTK | |
| SCHEMBL4823759 | 0.85 | EGFR (0.80) | EGFRIGF1RERBB4AURKBBTK | |
| Acetic Acid SCHEMBL6430342 | 0.85 | EGFR (0.59) | EGFRIGF1RERBB4AURKBBTK | |
| Acetic Acid SCHEMBL4827149 | 0.83 | BTK (0.48) | EGFRIGF1RERBB4BTKJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004100868-A2 | METHOD OF TREATING TRANSPLANT REJECTION | ABBOTT LABORATORIES (US) | 2004-11-25 | — | — | WO | disclosed |